Literature DB >> 18949403

The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.

Hong Zhou1, Hongxin Hu, Wenxia Shi, Shucai Ling, Ting Wang, Haibo Wang.   

Abstract

Tissue factor (TF) is believed to play an important role in tissue repair, inflammation, angiogenesis, and tumor metastasis. Protease-activated receptors (PARs) are widely expressed on various cells including tumor cells and associated with many pathological mechanisms. In the present study, the expression of TF and PAR1, PAR2 on human colon cancer cells (SW620 and SW480) was investigated and their functional roles on the behavior of tumor cells were evaluated. It was demonstrated that SW620 and SW480 cells expressed TF at antigen, activity and mRNA levels. However, the highly metastatic cell line SW620 showed slightly higher TF expression than the low metastatic cell line SW480. The PAR2 antigen was strongly expressed on the membrane of SW620 cells, but not on SW480 cells. The PAR1 antigen was not observed in SW620 or SW480 cells, while PAR1 and PAR2 mRNA was detected in SW620 and SW480 cells. The migratory potential of SW620 was stronger than that of SW480 seen in Boyden chambers. PAR2 agonist (SLIGKV-NH2) and factor VIIa significantly stimulated SW620 cell proliferation, migratory activity, and interleukin 8 (IL-8) secretion compared to control. The stimulating effects of factor VIIa could be inhibited by anti-TF and anti-PAR2 but not anti-PAR1 antibodies. In summary, this study demonstrates that TF and PAR2 are strongly expressed on highly metastatic colonic tumor cells and are closely associated with the proliferation and migration of the cells. TF may elucidate its roles in colonic cancer invasion and metastasis via PAR2 pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949403

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro.

Authors:  Fang Zhou; Hong Zhou; Ting Wang; Yuan Mu; Biao Wu; Dong-lin Guo; Xian-mei Zhang; Ying Wu
Journal:  Acta Pharmacol Sin       Date:  2011-11-21       Impact factor: 6.150

2.  Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.

Authors:  Biao Wu; Hong Zhou; Lichao Hu; Yuan Mu; Ying Wu
Journal:  Tumour Biol       Date:  2012-12-12

3.  Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.

Authors:  Donglin Guo; Hong Zhou; Ying Wu; Fang Zhou; Guoying Xu; Haiping Wen; Xianmei Zhang
Journal:  Tumour Biol       Date:  2011-05-28

4.  TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.

Authors:  Lichao Hu; Longfei Xia; Hong Zhou; Biao Wu; Yuan Mu; Ying Wu; Jinchuan Yan
Journal:  Tumour Biol       Date:  2013-04-25

5.  Development of coagulation factor probes for the identification of procoagulant circulating tumor cells.

Authors:  Garth W Tormoen; Flor A Cianchetti; Paul E Bock; Owen J T McCarty
Journal:  Front Oncol       Date:  2012-09-06       Impact factor: 6.244

6.  Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.

Authors:  Yitao Jia; Suqiao Zhang; Lingling Miao; Jingbao Wang; Zujian Jin; Bin Gu; Zhihui Duan; Zhaolong Zhao; Shunmao Ma; Wenjin Zhang; Zhongxin Li
Journal:  Oncol Rep       Date:  2015-04-03       Impact factor: 3.906

7.  Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells.

Authors:  Xiao Han; Haoran Zha; Fei Yang; Bo Guo; Bo Zhu
Journal:  Int J Mol Sci       Date:  2017-01-19       Impact factor: 5.923

8.  Platelet-derived extracellular vesicles inhibit ferroptosis and promote distant metastasis of nasopharyngeal carcinoma by upregulating ITGB3.

Authors:  Fei Li; Ting Xu; Peiling Chen; Rui Sun; Chaoyi Li; Xin Zhao; Jinxin Ou; Jingyao Li; Taoshu Liu; Maozhen Zeng; Weizhong Zheng; Yunchen Lin; Le Yang; Zecang Li; Haisheng Chen; Qing Zhang
Journal:  Int J Biol Sci       Date:  2022-09-24       Impact factor: 10.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.